A renaissance for SRC
The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This suggests that SRC activation may also be a dominant feature in CRC, which is supported by the observation that SRC activation was documented in > 80% of CRC [17].”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [17]
In the citing paper
“In response signaling from a variety of RTKs (including EGFR, HER2, HER4, PDGFR, VEGFR, FGFR4, GPCR, C-MET, IL-4/IL13/IL-13Rα2, IL-6ST/IL-6R/IL-11R), SRC has been reported to mediate diverse cell signaling pathways including RAS/MAPK (proliferation), PI3K/AKT (survival), FAK (adhesion/migration/EMT), and STAT3 (angiogenesis) [17, 49, 50].”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [17]
In the citing paper
“Aberrant SRC activation has been associated with a more aggressive phenotype and a worse prognosis in CRC patients [27, 28, 39].”
From Co-targeting SRC overcomes resistance to BRAF inhibitors in colorectal cancer (2025) · cites this paper as [39]
In the citing paper
“The c-src is a non-receptor protein tyrosine kinase with a 60-kD molecular weight.It is a member of a 9-gene family named the Src family kinases (SFKs)”
From The molecular rationale of Src inhibition in colorectal carcinomas (2014) · cites this paper as [1]
Citations
Cites
Integrins: Versatility, modulation, and signaling in cell adhesion
Hynes, R. O. (1992) · Cell · doi:10.1016/0092-8674(92)90115-s · Cited by 9,859 · cited 1×
“Focal adhesions are also disassembled during transformation, during which the integrity of these structures is disrupted, permitting increased motilit”
BackgroundCell Migration: A Physically Integrated Molecular Process
Lauffenburger, D. A., & Horwitz, A. F. (1996) · Cell · doi:10.1016/s0092-8674(00)81280-5 · Cited by 3,915 · cited 1×
“This is followed by release of adhesions and retraction of the rear en”
BackgroundGiancotti, F. G., & Ruoslahti, E. (1999) · Science · doi:10.1126/science.285.5430.1028 · Cited by 3,869
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345 · cited 1×
“Although not yet reported for c- SRC , it has been possible to transform human fibroblasts with oncogenes such as HRAS when they are combined with human telomerase reverse transcriptase and the SV40 large T antige”
BackgroundTransforming gene product of Rous sarcoma virus phosphorylates tyrosine
Hunter, T., & Sefton, B. M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1311 · Cited by 2,332 · cited 1×
“v- src was subsequently shown to encode a tyrosine-specific protein kinas”
BackgroundThe STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278 · cited 1×
“STAT3 activation by v-Src has also been shown to contribute to other biological properties of cancer cells, including cell growth and survival, and tumour-cell immune evasio”
BackgroundFOCAL ADHESIONS, CONTRACTILITY, AND SIGNALING
Burridge, K., & Chrzanowska-Wodnicka, M. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.463 · Cited by 1,942 · cited 1×
“Small adhesions can transmit stong forces for rapid movement and ultimately mature into larger focal adhesion”
BackgroundReduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice
llić, D., Furuta, Y., Kanazawa, S., Takeda, N., Sobue, K., Nakatsuji, N., Nomura, S., Fujimoto, J., Okada, M., Yamamoto, T., et al. (1995) · Nature · doi:10.1038/377539a0 · Cited by 1,830
E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.
Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Löchner, D., & Birchmeier, W. (1991) · The Journal of cell biology · doi:10.1083/jcb.113.1.173 · Cited by 1,551 · cited 1×
“Definitive studies in transgenic mice indicate that E-cadherin is an invasion suppresso”
BackgroundA causal role for E-cadherin in the transition from adenoma to carcinoma
Perl, A.-K., Wilgenbus, P., Dahl, U., Semb, H., & Christofori, G. (1998) · Nature · doi:10.1038/32433 · Cited by 1,424 · cited 1×
“and overexpression of E-cadherin can, in fact, counteract the acquisition of the invasive phenotyp”
Background
Cited by
Items 201–300 of 999
SRC family kinases in cell volume regulation
Cohen, D. M. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00452.2004 · Cited by 84
“Activated SRC, for example, traffics to the cell membrane where amino terminal myristoylation or palmitoylation anchors it to the inner leaflet (135, 158).”
BackgroundMund, T., & Pelham, H. R. B. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911714107 · Cited by 95
“However, because Y73 seemed important for further modification of Ndfip2, we considered the possibility that phosphorylation of this residue aids interaction with the kinases by providing an additional binding site for their SH2 domains (21).”
Backgroundp140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity
Stefano, P. D., Damiano, L., Cabodi, S., Aramu, S., Tordella, L., Praduroux, A., Piva, R., Cavallo, F., Forni, G., Silengo, L., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601724 · Cited by 89
“In the early phases of cell-matrix adhesion, cell spreading and migration might depend on Src kinase activation (Yeatman, 2004) and on Rac GTPase (Burridge and Wennerberg, 2004).”
BackgroundMarquardt, J. U., Raggi, C., Andersen, J. B., Seo, D., Avital, I., Geller, D., Lee, Y.-H., Kitade, M., Holczbauer, A., Gillen, M. C., et al. (2011) · Hepatology · doi:10.1002/hep.24454 · Cited by 84
Wang, X.-D., Reeves, K., Luo, F. R., Xu, L.-A., Lee, F., Clark, E., & Huang, F. (2007) · Genome Biology · doi:10.1186/gb-2007-8-11-r255 · Cited by 83
“Since these two types of cells are able to self-renew and quickly proliferate to give rise to new or more differentiated cells, an intrinsic relationship may exist between the expression and function of dasatinib targets such as the SFK LYN and the proliferation of these cells [11].”
BackgroundChua, K.-N., Sim, W.-J., Racine, V., Lee, S.-Y., Goh, B. C., & Thiery, J. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033183 · Cited by 82
“while PI3K predominately regulates cell proliferation [24-26].”
Diacylglycerol kinases in cancer
Mérida, I., Torres‐Ayuso, P., Ávila‐Flores, A., Arranz‐Nicolás, J., Andrada, E., Tello‐Lafoz, M., Liébana, R., & Arcos, R. (2016) · Advances in Biological Regulation · doi:10.1016/j.jbior.2016.09.005 · Cited by 85
Src Regulates Actin Dynamics and Invasion of Malignant Glial Cells in Three Dimensions
Angers‐Loustau, A., Hering, R., Werbowetski‐Ogilvie, T. E., Kaplan, D. R., & Maestro, R. F. D. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.595.2.11 · Cited by 90
Hanson, R. L., & Hollingsworth, M. A. (2016) · Biomolecules · doi:10.3390/biom6030034 · Cited by 97
“a potential link between the expression of truncated glycans, GalNAc-T localization, and an aggressive tumor phenotype [52,62,63,67].”
BackgroundWang, Y., Cao, H., Chen, J., & McNiven, M. A. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-09-0785 · Cited by 81
“A specific tyrosine residue in the SH2 domain of FAK (pTyr-397) is known to both bind and activate Src by disrupting its autoinhibitory conformation (Yeatman, 2004).”
BackgroundTargeting Src Family Kinases Inhibits Bevacizumab-Induced Glioma Cell Invasion
Deborah, H., Lewis‐Tuffin, L. J., Carlson, B. L., Schroeder, M. A., Rodríguez, F. J., Giannini, C., Galanis, E., Sarkaria, J. N., & Anastasiadis, P. Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056505 · Cited by 89
“Conversely, the Src-mediated migration of T98G cells in vitro and in vivo is selectively inhibited by dasatinib [16], a potent multitargeted kinase inhibitor that inhibits all SFKs [18,21].”
BackgroundMethodInfluentialGe, Y., Fan, X., & Chen, P. R. (2016) · Chemical Science · doi:10.1039/c6sc02615j · Cited by 81
Rho GTPases and related signaling complexes in cell migration and invasion
Guan, X., Guan, X., Dong, C., & Jiao, Z. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.111824 · Cited by 92
Hu, L., Fan, M., Shi, S., Song, X., Wang, F., He, H., & Qi, B. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113963 · Cited by 86
c-Src and EGFR Inhibition in Molecular Cancer Therapy: What Else Can We Improve?
Belli, S., Esposito, D., Servetto, A., Pesapane, A., Formisano, L., & Bianco, R. (2020) · Cancers · doi:10.3390/cancers12061489 · Cited by 89
“Likewise, activated growth-factor receptors can associate with the c-Src SH2 domain, prompting c-Src activation by a similar mechanism [1,8,11].”
BackgroundAmmer, A. G., Kelley, L. C., Hayes, K. E., Evans, J. V., Lopez-Skinner, L. A., Martin, K. H., Frederick, B. A., Rothschild, B. L., Raben, D., Elvin, P., et al. (2009) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000009 · Cited by 86
“…supports this conclusion, as signaling Journal of Cancer Science & Therapy - Open Access JCST/Vol.1 Issue 2 J Cancer Sci Ther Volume 1(2) : 052-061 (2009) - 059 ISSN:1948-5956 JCST, an open access journal through these proteins promotes invasion and metastatic spread (Weaver, 2008; Yeatman, 2004).”
BackgroundResultPérez, Y., Gairí, M., Pons, M., & Bernadó, P. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.06.018 · Cited by 90
Summy, J. M., Trevino, J. G., Lesslie, D. P., Baker, C. H., Shakespeare, W. C., Wang, Y., Sundaramoorthi, R., Metcalf, C. A., Keats, J. A., Sawyer, T. K., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0171 · Cited by 79
“The Src family kinases are composed of nine structurally related, membrane-associated, nonreceptor protein tyrosine kinases (1, 2).”
BackgroundTrop‐2 inhibits prostate cancer cell adhesion to fibronectin through the β1 integrin‐RACK1 axis
Trerotola, M., Li, J., Alberti, S., & Languino, L. R. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24074 · Cited by 78
“While FAK and Src have intrinsic kinase activities (Lu et al., 1997; Marx et al., 2001; Yeatman, 2004; Mitra et al., 2005), RACK1 is an adaptor molecule known to bind several key signaling proteins, such as activated PKCs (Ron et al., 1994), FAK (Kiely et al., 2009; Serrels et al., 2010) and Src…”
Humbert, M., Castéran, N., Letard, S., Hanssens, K., Iovanna, J., Finetti, P., Bertucci, F., Bader, T., Mansfield, C. D., Moussy, A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009430 · Cited by 78
“In particular, gemcitabine resistance in pancreatic cancer is often associated with high expression of focal adhesion kinase (FAK) [8], a protein involved in metastasis; and elevated expression and activity of Src Family Kinases (SFK), including SRC and Lyn, have also been reported in numerous human cancer cell lines…”
BackgroundGrowth factor signaling pathways as targets for prevention of epithelial carcinogenesis
Rho, O., Kim, D. J., Kiguchi, K., & DiGiovanni, J. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20665 · Cited by 84
“After activation, Src subsequently activates its downstream targets including focal adhesion kinase, PI3K, and Stat3 [103,104].”
BackgroundOptogenetically controlled protein kinases for regulation of cellular signaling
Leopold, A. V., Chernov, K. G., & Verkhusha, V. V. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00404d · Cited by 84
Tyrosine phosphorylation of paxillin affects the metastatic potential of human osteosarcoma
Azuma, K., Tanaka, M., Uekita, T., Inoue, S., Yokota, J., Ouchi, Y., & Sakai, R. (2005) · Oncogene · doi:10.1038/sj.onc.1208654 · Cited by 86
c‐Src drives intestinal regeneration and transformation
Cordero, J. B., Ridgway, R. A., Valeri, N., Nixon, C., Frame, M. C., Muller, W. J., Vidal, M., & Sansom, O. J. (2014) · The EMBO Journal · doi:10.1002/embj.201387454 · Cited by 77
Alternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion
Vlahov, N., Scrace, S., Soto, M. S., Grawenda, A. M., Bradley, L., Paňková, D., Papaspyropoulos, A., Yee, K. S. Y., Buffa, F. M., Goding, C. R., et al. (2015) · Current Biology · doi:10.1016/j.cub.2015.09.072 · Cited by 84
“Deregulation of these activities promotes tumorigenesis, cancer cell invasion, and metastasis [46].”
BackgroundHwang, J. W., Kim, S., Myung, N., Song, D., Han, G., Bae, G., Bedford, M. T., & Kim, Y. K. (2020) · Communications Biology · doi:10.1038/s42003-020-01157-z · Cited by 85
Cortés‐Reynosa, P., Robledo, T., Macías‐Silva, M., Wu, S. S., & Salazar, E. P. (2007) · Matrix Biology · doi:10.1016/j.matbio.2007.11.003 · Cited by 79
“In addition, Src also affects cell adhesion and invasion and has been linked to the development of tumor metastasis (Yeatman, 2004).”
BackgroundFury, M. G., Baxi, S. S., Shen, R., Kelly, K. W., Lipson, B. L., Carlson, D. L., Stambuk, H. E., Haque, S. S., & Pfister, D. G. (2011) · PubMed · Cited by 89
Nam, S., Wen, W. X., Schroeder, A., Herrmann, A., Yu, H., Cheng, X., Merz, K., Eisenbrand, G., Li, H., Yuan, Y., et al. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.10.013 · Cited by 75
“Levels of expression and activity of SFKs are elevated in a variety of human cancer cell lines and patient tumors (Kim et al., 2009; Parsons and Parsons, 2004; Yeatman, 2004).”
BackgroundYu, Y., Anjum, R. S., Kubota, K., Rush, A. J., Villén, J., & Gygi, S. P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905165106 · Cited by 81
“Although a deregulated PI3K-, MAPK-, Src-, or the cyclindependent kinase-mediated signaling pathway is often an obligatory event in tumorgenisis (2, 4), we are currently expanding our peptide substrate catalog to target kinases implicated in other pathophysiological processes, including casein-kinases, GSK3, ATM/ATR,…”
BackgroundAn Update on Src Family of Nonreceptor Tyrosine Kinases Biology
Espada, J., & Martín-Pérez, J. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.09.009 · Cited by 87
Byun, S., Kim, D.-H., Ryerson, D., Kim, Y.-C., Sun, H., Kong, B., Yau, P., Guo, G., Xu, H. E., Kemper, B., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04697-5 · Cited by 75
Crystal Structures of Active Src Kinase Domain Complexes
Breitenlechner, C. B., Kairies, N., Honold, K., Scheiblich, S., Koll, H., Greiter, E., Koch, S., Schäfer, W., Huber, R., & Engh, R. A. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.08.023 · Cited by 76
Wilson, G., Cramer, A., Welman, A., Knox, F., Swindell, R., Kawakatsu, H., Clarke, R. B., Dive, C., & Bundred, N. J. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603444 · Cited by 74
“Elevated c-Src activity leads to inhibition of matrix metalloproteinases (Noritake et al, 1999), disruption of cell–cell adhesions (Yeatman, 2004) and enhances the migratory potential of tumour cells (Frame, 2002).”
BackgroundSerrels, A., Canel, M., Brunton, V. G., & Frame, M. C. (2011) · Cell Adhesion & Migration · doi:10.4161/cam.5.4.17290 · Cited by 81
Dual targeting of Src and ER prevents acquired antihormone resistance in breast cancer cells
Hiscox, S., Jordan, N., Smith, C., James, M., Morgan, L. D., Taylor, K. M., Green, T. P., & Nicholson, R. I. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0058-6 · Cited by 82
“Overexpression of the non-receptor tyrosine kinase, Src, and/or an increase in its kinase activity has been associated with the development and progression of a number of human malignancies including breast cancer [12, 13] where S.”
BackgroundThe Src signaling pathway: a potential target in melanoma and other malignancies
Homsi, J., Cubitt, C. L., & DAUD, A. I. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.1.91 · Cited by 83
“The disruption of both the adherens junctions and the focal-adhesion (both regulated by c-Src) is required for the disruption of cellular motility [21].”
BackgroundFyn Kinase in Brain Diseases and Cancer: The Search for Inhibitors
Schenone, S., Brullo, C., Musumeci, F., Biava, M., Falchi, F., & Botta, M. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796150531 · Cited by 74
“As other SFK members, Fyn is implicated in several physiological processes, including not only cellular growth and proliferation, but also morphogenesis and cellular motility, whose aberration may cause cancer development [68].”
BackgroundEphA2 and Src regulate equatorial cell morphogenesis during lens development
Cheng, C., Ansari, M. M., Cooper, J. A., & Gong, X. (2013) · Development · doi:10.1242/dev.100727 · Cited by 77
“…homeostasis and in a vast range of physiological functions including cell proliferation and survival, cell shape control, regulation of the cytoskeleton, maintenance of normal intercellular contacts, cell-matrix adhesion dynamics, motility and migration (Thomas and Brugge, 1997; Yeatman, 2004).”
Chang, A. Y., & Wang, M. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-267 · Cited by 74
“These findings indicated that EGFR may be a direct target of dasatinib or an indirect target secondary to Src inhibition [8,11].”
Target-based therapies in breast cancer: current status and future perspectives
Normanno, N., Morabito, A., Luca, A. D., Piccirillo, M. C., Gallo, M., Maiello, M. R., & Perrone, F. (2009) · Endocrine Related Cancer · doi:10.1677/erc-08-0208 · Cited by 94
“Src can be activated by cytoplasmic proteins, such as focal adhesion kinase (FAK) or its molecular partner Crkassociated substrate, which is involved in integrin signaling, and by ligand-activated tyrosine kinases of cell surface receptors, including EGFR and ErbB-2 (Yeatman 2004).”
BackgroundInfluentialSrc controls tumorigenesis via JNK‐dependent regulation of the Hippo pathway in Drosophila
Enomoto, M., & Igaki, T. (2013) · EMBO reports · doi:10.1038/embor.2012.185 · Cited by 72
“While it has been documented that Src is a potent inducer of tumorigenesis and its expression is highly elevated in many types of epithelial cancers [7,8], the mechanism by which Src drives tumorigenesis within multicellular communities in vivo has remained unclear.”
Bone Metastases: Molecular Mechanisms and Novel Therapeutic Interventions
Papachristou, D. J., Basdra, E. K., & Papavassiliou, A. G. (2010) · Medicinal Research Reviews · doi:10.1002/med.20224 · Cited by 81
“Src is the prototypic member of a nonreceptor tyrosine kinase family, the Src family kinases.(129,130) Src is involved in numerous critical cell functions, including cell morphology, cell growth, proliferation and differentiation, adhesion, migration, and survival.”
BackgroundStructure of a novel phosphotyrosine‐binding domain in Hakai that targets E‐cadherin
Mukherjee, M., Chow, S. Y., Yusoff, P., Seetharaman, J., Ng, C., Sinniah, S., Koh, X. W., Asgar, N. F., Li, D., Yim, D., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.496 · Cited by 87
“Interestingly, this may indicate a bias towards Src substrates because Src kinase has a preferred, but not strict, recognition sequence of Y(p)-E-E-I/V (Yeatman, 2004).”
MiR-424/503-Mediated Rictor Upregulation Promotes Tumor Progression
Oneyama, C., Kito, Y., Asai, R., Ikeda, J., Yoshida, T., Okuzaki, D., Kokuda, R., Kakumoto, K., Takayama, K., Inoue, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080300 · Cited by 71
“The tyrosine kinase c-Src is upregulated in various human cancers and plays a crucial role in tumor progression [25-29].”
BackgroundFormisano, L., Nappi, L., Rosa, R., Marciano, R., D’Amato, C., D’Amato, V., Damiano, V., Raimondo, L., Iommelli, F., Scorziello, A., et al. (2014) · Breast Cancer Research · doi:10.1186/bcr3650 · Cited by 73
“Through these interactions, Src controls cell growth and survival by modulating the activity of such intracellular effectors as PI3K/Akt and signal transducer and activator of transcription 3 (STAT3) [11].”
RetractedMasraksa, W., Tanasawet, S., Hutamekalin, P., Wongtawatchai, T., & Sukketsiri, W. (2020) · Nutrition Research and Practice · doi:10.4162/nrp.2020.14.2.127 · Cited by 76
“Besides, FAK and Src activation has been established in highly metastatic cancer cells [8-10].”
BackgroundGiamougiannis, P., Martin‐Hirsch, P. L., & Martin, F. L. (2021) · Carcinogenesis · doi:10.1093/carcin/bgab010 · Cited by 77
Anin vitrocorrelation of mechanical forces and metastatic capacity
Indra, I., Undyala, V. V. R., Kandow, C. E., Thirumurthi, U., Dembo, M., & Beningo, K. A. (2011) · Physical Biology · doi:10.1088/1478-3975/8/1/015015 · Cited by 85
“Consistent with previous observations (Cavallaro and Christofori 2001, Yeatman 2004, Mierke 2008), we found that enhanced metastatic capacity indeed reduces cell–substrate adhesion strength in two dimensions.”
ResultMolecular Regulation of Sprouting Angiogenesis
Duran, C. L., Howell, D. W., Dave, J. M., Smith, R. L., Torrie, M. E., Essner, J. J., & Bayless, K. J. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160048 · Cited by 86
Oncogenic Src requires a wild-type counterpart to regulate invadopodia maturation
Kelley, L. C., Ammer, A. G., Hayes, K. E., Martin, K. H., Machida, K., Jia, L., Mayer, B. J., & Weed, S. A. (2010) · Journal of Cell Science · doi:10.1242/jcs.075200 · Cited by 70
Analyses of rare predisposing variants of lung cancer in 6,004 whole genomes in Chinese
Wang, C., Dai, J., Qin, N., Fan, J., Ma, H., Chen, C., An, M., Zhang, J., Yan, C., Gu, Y., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.08.013 · Cited by 78
Yoo, Y., Ho, H. J., Wang, C., & Guan, J. (2009) · Oncogene · doi:10.1038/onc.2009.319 · Cited by 78
“A highly activated viral counterpart of Src, v-Src, is responsible for the transforming properties of Rous Sarcoma virus (Yeatman, 2004).”
Rao, V. K., Chhikara, B. S., Shirazi, A. N., Tiwari, R. K., Parang, K., & Kumar, A. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.05.010 · Cited by 70
Elsberger, B., Fullerton, R., Zino, S., Jordan, F., Mitchell, T. J., Brunton, V. G., Mallon, E. A., Shiels, P. G., & Edwards, J. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605829 · Cited by 70
“Elevated c-Src activity promotes cellular invasion and motility in tamoxifen-resistant breast cancer cells (Hiscox et al, 2006) and provides a link between the HER family and steroid receptors (Yeatman, 2004; Likhite et al, 2006).”
Src‐Tyrosine kinases are major agents in mitochondrial tyrosine phosphorylation
Tibaldi, E. V., Brunati, A. M., Massimino, M. L., Stringaro, A., Colone, M., Agostinelli, E., Arancia, G., & Toninello, A. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21670 · Cited by 76
Sharma, S., Singh, J., Ojha, R., Singh, H., Kaur, M., Bedi, P. M. S., & Nepali, K. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.02.018 · Cited by 75
Lupo, F., Tibaldi, E. V., Mattè, A., Sharma, A. K., Brunati, A. M., Alper, S. L., Zancanaro, C., Benati, D., Siciliano, A., Bertoldi, M., et al. (2016) · Blood · doi:10.1182/blood-2016-07-727321 · Cited by 70
“Studies in other cell models have shown that accumulation of SFKs might be related to perturbation of protein quality control related to autophagy.(56,57,69) Indeed, chorea-acanthocytosis red cells revealed accumulation of autophagy-related proteins Ulk1, Atg7, Atg13, and cytosolic LC3 compared with healthy erythrocyt…”
BackgroundSirvent, A., Bénistant, C., Pannequin, J., Veracini, L., Simon, V, Bourgaux, J.-F., Hollande, F., Cruzalegui, F., & Roche, S. (2010) · Oncogene · doi:10.1038/onc.2009.450 · Cited by 69
“While protein overexpression clearly provides part of the response (Yeatman, 2004), additional mechanisms are expected to de-repress their catalytic activity.”
BackgroundInfluentialMicroRNA-mediated upregulation of integrin-linked kinase promotes Src-induced tumor progression
Oneyama, C., Morii, E., Okuzaki, D., Takahashi, Y., Ikeda, J., Wakabayashi, N., Akamatsu, H., Tsujimoto, M., Nishida, T., Aozasa, K., et al. (2011) · Oncogene · doi:10.1038/onc.2011.367 · Cited by 70
“…that are tightly associated with tumor progression (Brown and Cooper, 1996; Ingley, 2008). c-Src is frequently overexpressed and activated in a wide variety of human cancers, suggesting that it actively facilitates tumor progression (Frame, 2002; Ishizawar and Parsons, 2004; Yeatman, 2004).”
BackgroundZhang, S., Yang, Z., Bao, W., Liu, L., You, Y., Wang, X., Shao, L., Fu, W., Kou, X., Shen, W., et al. (2019) · Autophagy · doi:10.1080/15548627.2019.1632122 · Cited by 80
Treatment options for patients with triple-negative breast cancer
Santana-Dávila, R., & Perez, E. A. (2010) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-3-42 · Cited by 76
“It plays an important role in cancer cell proliferation and invasion through multiple pathways [90,91].”
BackgroundRedox Circuitries Driving Src Regulation
Giannoni, E., & Chiarugi, P. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5525 · Cited by 69
“…include 11 members, Blk, Brk, Fgr, Frk, Fyn, Hck, Lck, Lyn, c-Src, Srm, and Yes (101, 102). c-Src c-Src, the prototypic member of this family, plays important roles in a vast range of physiological functions, including cell proliferation and survival, cell morphology, adhesion, and motility (134).”
Galanis, E., Anderson, S. K., Twohy, E. L., Carrero, X. W., Dixon, J. G., Tran, D. D., Jeyapalan, S. A., Anderson, D. M., Kaufmann, T. J., Feathers, R. W., et al. (2019) · Cancer · doi:10.1002/cncr.32340 · Cited by 75
“An increase in Src family kinase (SFK) activation commonly is noted in patients with GBM and is associated with increased tumor cell invasion and motility.(16)”
Backgroundc-Src Promotes Tumorigenesis and Tumor Progression by Activating PFKFB3
Ma, H., Zhang, J., Zhou, L., Wen, S., Tang, H.-Y., Jiang, B., Zhang, F., Suleman, M., Sun, D., Chen, A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.03.005 · Cited by 71
Sirvent, A., Boureux, A., Simon, V., Leroy, C., & Roche, S. (2007) · Oncogene · doi:10.1038/sj.onc.1210543 · Cited by 70
“Instead, overexpression and/or protein stabilization may contribute to its deregulation, although alternative mechanisms can be expected (Yeatman, 2004).”
BackgroundOkochi, M., Takano, S., 伊佐治弥生, Senga, T., Hamaguchi, M., & Honda, H. (2009) · Lab on a Chip · doi:10.1039/b909304d · Cited by 72
Hingorani, P., Zhang, W., Gorlick, R., & Kolb, E. A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1657 · Cited by 68
Src activation in melanoma and Src inhibitors as therapeutic agents in melanoma
Homsi, J., Cubitt, C. L., Zhang, S., Munster, P. N., Yu, H., Sullivan, D. M., Jove, R., Messina, J. L., & Daud, A. I. (2009) · Melanoma Research · doi:10.1097/cmr.0b013e328304974c · Cited by 67
PTPL1/PTPN13 Regulates Breast Cancer Cell Aggressiveness through Direct Inactivation of Src Kinase
Glondu-Lassis, M., Dromard, M., Lacroix‐Triki, M., Nirdé, P., Puech, C., Knani, D., Chalbos, D., & Freiss, G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4368 · Cited by 67
“Thus, in human cancers, elevated Src activity has been shown to increase growth rate (30) and migratory and metastatic potential (31) while inhibiting cell-cell adhesion (32).”
Multi-Conformer Ensemble Docking to Difficult Protein Targets
Ellingson, S. R., Miao, Y., Baudry, J. Y., & Smith, J. C. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp506511p · Cited by 69
Metformin promotes apoptosis in hepatocellular carcinoma through the CEBPD-induced autophagy pathway
Tsai, H.-H., Lai, H.-Y., Chen, Y.-C., Li, C.-F., Huang, H.-S., Liu, H.-S., Tsai, Y.-S., & Wang, J.-M. (2017) · Oncotarget · doi:10.18632/oncotarget.14640 · Cited by 67
“The roles of Src in promoting tumor progression and metastasis have been well documented [35].”
BackgroundSRC Signaling Is Crucial in the Growth of Synovial Sarcoma Cells
Michels, S. Y. F., Trautmann, M., Sievers, E., Kindler, D., Huss, S., Renner, M., Friedrichs, N., Kirfel, J., Steiner, S., Endl, E., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3023 · Cited by 71
Lee, G.-H., Yoo, K.-C., An, Y., Lee, H., Lee, M. Y., Uddin, N., Kim, M.-J., Kim, I. G., Suh, Y., & Lee, S. (2018) · Oncogene · doi:10.1038/s41388-017-0114-y · Cited by 69
Nectin and Nectin-Like Molecules: Biology and Pathology
Miyoshi, J., & Takai, Y. (2007) · American Journal of Nephrology · doi:10.1159/000108103 · Cited by 71
Bretz, N. P., Noske, A., Keller, S., Erbe-Hoffmann, N., Schlange, T., Salnikov, A. V., Moldenhauer, G., Kristiansen, G., & Altevogt, P. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9426-4 · Cited by 73
“phatases [52, 53].”
A HIF-Regulated VHL-PTP1B-Src Signaling Axis Identifies a Therapeutic Target in Renal Cell Carcinoma
Suwaki, N., Vanhecke, E., Atkins, K. M., Graf, M., Swabey, K., Huang, P., Schraml, P., Moch, H., Cassidy, A. M., Brewer, D., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002004 · Cited by 66
Awakura, Y., Nakamura, E., Takahashi, T., Kotani, H., Mikami, Y., Kadowaki, T., Myoumoto, A., Akiyama, H., Ito, N., Kamoto, T., et al. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0412-4 · Cited by 66
“Further analysis detailing the relationship between src activation and CDCP1 expression in RCC might become relevant to clinical practice because several src kinase inhibitors have been developed and have undergone clinical trials in other types of cancers (Yeatman 2004).”
Wang, W., Liu, Y., & Liao, K. (2011) · BMC Cell Biology · doi:10.1186/1471-2121-12-49 · Cited by 75
“In cancer cells, active Src not only increases cell growth and survival, but also promotes actin cytoskeleton reorganization and decreases cell-cell and cellmatrix adhesions to facilitate motility and invasiveness [1,3].”
BackgroundFallah‐Tafti, A., Foroumadi, A., Tiwari, R. K., Shirazi, A. N., Hangauer, D. G., Bu, Y., Akbarzadeh, T., Parang, K., & Shafiee, A. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.07.050 · Cited by 66
Na,K-ATPase activity modulates Src activation: A role for ATP/ADP ratio
Weigand, K. M., Swarts, H. G. P., Fedosova, N. U., Rüssel, F. G. M., & Koenderink, J. B. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.01.015 · Cited by 65
Arcaroli, J. J., Touban, B. M., Tan, A. C., Varella-Garcia, M., Powell, R. W., Eckhardt, S. G., Elvin, P., Gao, D., & Messersmith, W. A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0066 · Cited by 64
Hébert-Chatelain, É., José, C., Cortés, N. G., Dupuy, J., Rocher, C., Dachary-Prigent, J., & Letellier, T. (2012) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.01.014 · Cited by 70
“The Src and Lck-mediated phosphorylation of Y190 and Y194 in adenine nucleotide translocase was shown to be involved in its carrier function and in the respiration of yeast [10].”
BackgroundSrc kinases are important regulators of mitochondrial functions
Hébert-Chatelain, É. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.08.014 · Cited by 74
Lyn is involved in CD24-induced ERK1/2 activation in colorectal cancer
Su, N., Peng, L., Xia, B., Zhao, Y., Xu, A., Wang, J., Wang, X., & Jiang, B. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-43 · Cited by 71
“SFKs are a family of non receptor-type tyrosine kinases and include at least nine highly homologous proteins in mammals [15,16].”
Okamoto, W., Okamoto, I., Yoshida, T., Okamoto, K., Takezawa, K., Hatashita, E., Yamada, Y., Kuwata, K., Arao, T., Yanagihara, K., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0002 · Cited by 64
Pantic, B., Trevisan, E., Citta, A., Rigobello, M. P., Marin, O., Bernardi, P., Salvatori, S., & Rasola, A. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.385 · Cited by 69
“Src activation is a master event in the preservation of normal cell homeostasis, and it regulates cytoskeleton organization, maintenance of normal intercellular contacts, and cell adhesion, motility, proliferation and survival.(44) A growing body of evidence indicates that Src has a pivotal role in the Tyr phosphoryla…”
BackgroundAmata, I., Maffei, M., Igea, A., Gay, M., Vilaseca, M., Nebreda, Á. R., & Pons, M. (2013) · ChemBioChem · doi:10.1002/cbic.201300139 · Cited by 63
The Tumor Suppressor Functions of p27kip1 Include Control of the Mesenchymal/Amoeboid Transition
Berton, S., Belletti, B., Wolf, K., Canzonieri, V., Lovat, F., Vecchione, A. M., Colombatti, A., Friedl, P., & Baldassarre, G. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00144-09 · Cited by 71
c-Src inactivation reduces renal epithelial cell-matrix adhesion, proliferation, and cyst formation.
Elliott, J., Zheleznova, N. N., & Wilson, P. (2011) · American Journal of Physiology - Cell Physiology · doi:10.1152/ajpcell.00163.2010 · Cited by 70
“It is well established that overexpression or overactivation of c-Src is often associated with carcinogenesis and plays multiple roles in the regulation of proliferation, cell-ECM adhesion, invasion, and motility (52).”
BackgroundSrc family kinases differentially influence glioma growth and motility
Lewis‐Tuffin, L. J., Feathers, R. W., Hari, P., Durand, N., Li, Z., Rodríguez, F. J., Bakken, K., Carlson, B. L., Schroeder, M. A., Sarkaria, J. N., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.06.001 · Cited by 66
“Src-family kinases (SFKs) are a series of nine membraneassociated, non-receptor tyrosine kinases (c-Src, Fyn, Yes, Lyn, Lck, Blk, Fgr, Hck, and Yrk), of which c-Src (henceforth referred to as Src) is the original, prototypical, and beststudied family member (Thomas and Brugge, 1997; Yeatman, 2004).”
Spreafico, A., Schenone, S., Serchi, T., Orlandini, M., Angelucci, A., Magrini, D., Bernardini, G., Collodel, G., Di Stefano, A., Tintori, C., et al. (2008) · The FASEB Journal · doi:10.1096/fj.07-9873com · Cited by 63
Ahmed, H. E. A., El-Nassag, M. A. A., Hassan, A. A. E.-H., Okasha, R. M., Ihmaid, S. K., Fouda, A. M., Afifi, T. H., Aljuhani, A., & El-Agrody, A. M. (2018) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1476503 · Cited by 63
“…plays essential roles in controlling a myriad of fundamental cellular processes, including cell proliferation, adhesion, migration, and invasion 39,40 . c-Src kinase is overexpressed and/or is aberrantly activated in a variety of human tumours, including breast, colon, pancreatic, bladder,…”
Dey, N., De, P. K., Wang, M., Zhang, H., Dobrota, E. A., Robertson, K. A., & Durden, D. L. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01352-06 · Cited by 62
“The SFKs are one of the oldest, largest (comprised of 11 members in humans, of which c-SRC, FYN, and YES are ubiquitously expressed), and most studied family of nonreceptor protein tyrosine kinases (8, 47, 68, 73).”
BackgroundOneyama, C., Iino, T., Saito, K., Suzuki, K., Ogawa, A., & Okada, M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00941-09 · Cited by 70
“In a variety of human cancers, protein levels and/or specific activities of c-Src and c-Yes are frequently upregulated (13, 35).”
BackgroundPark, S. I., Shah, A. N., Zhang, J., & Gallick, G. E. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.9.1207 · Cited by 70
Regan, K., Li, D., Reyes, R., Yu, L., Wani, N. A., Hu, P., Jacob, S. T., Ghoshal, K., Payne, P., & Motiwala, T. (2020) · Cancers · doi:10.3390/cancers12102730 · Cited by 64
Lei, K., Townsend, D. M., & Tew, K. D. (2008) · Oncogene · doi:10.1038/onc.2008.132 · Cited by 69
Huber, R., Pietsch, D., Günther, J., Welz, B., Vogt, N., & Brand, K. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1322-4 · Cited by 70
“Src, which is an activator of STAT3 and (via FAK/JNK) Jun proteins [172], is significantly induced and activated during PMA-induced monocytic differentiation of U937 and HL-60 cells [181].”
BackgroundΔαλέτος, Γ., de Voogd, N. J., Müller, W. E. G., Wray, V., Lin, W., Feger, D., Kubbutat, M. H. G., Aly, A. H., & Proksch, P. (2014) · Journal of Natural Products · doi:10.1021/np400633m · Cited by 66
Metadata
- Authors
- Yeatman, T. J.
- Affiliations
- Moffitt Cancer Center (US)
- Corresponding author
- Yeatman, Timothy J.
- ORCID
- Yeatman, Timothy J.
- Venue
- Nature Reviews Cancer
- Published
- 2004-06-01
- Volume
- 4
- Issue
- 6
- Pages
- 470-480
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2036988959
- Cited by
- 1,113
- References
- 115
- Citations by year
- 2026: 17 · 2025: 21 · 2024: 20 · 2023: 43 · 2022: 43 · 2021: 46 · 2020: 44 · 2019: 39 · 2018: 49 · 2017: 44 · 2016: 69 · 2015: 56 · 2014: 72 · 2013: 79 · 2012: 73
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- Src kinase, non-receptor tyrosine kinase, cancer, metastasis, cell invasion, cell motility, cell proliferation, anticancer agents, tumor progression
- MeSH terms
- Antineoplastic Agents, Cell Division, Humans, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Phenotype, Gene Expression Regulation, Neoplastic, Genes, src, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.